VANACOF CP ALLERGY / COUGH- chlophedianol hcl, pyrilamine maleate solution 
GM Pharmaceuticals, INC

----------

VANACOF CP Allergy / Cough

Active Ingredients (in each 15 mL (1TBSP))

Chlophedianol HCl 12.5 mg

Pyrilamine Maleate 25 mg

Purpose

Cough Suppressant

Antihistamine

Uses

■ temporarily relieves these symptoms due to the common cold, hay fever or other upper respiratory allergies:
■ runny nose ■ itching of the nose or throat
■ sneezing ■ itchy, watery eyes
■ cough due to minor throat and bronchial irritation

Warnings

Ask a doctor before use if you have

■ a cough that lasts or is chronic such as occurs with smoking, asthma, or emphysema
■ glaucoma
■ difficulty in urination due to enlargement of the prostate gland
■ a cough that occurs with too much phlegm (mucus)
■ a breathing problem such as emphysema or chronic bronchitis

Ask a doctor before use if you are

taking sedatives or tranquilizers

When using this product

■ do not use more than directed ■ avoid alcoholic drinks
■ marked drowsiness may occur
■ alcohol, sedatives, and tranquilizers may increase drowsiness
■ be careful when driving a motor vehicle or operating machinery
■ excitability may occur, especially in children

Stop use and ask a doctor if

  • ■ nervousness, dizziness, or sleeplessness occurs
  • ■ symptoms do not improve within 7 days, tend to recur, or are accompanied by a fever, rash or persistent headache. A persistent cough may be a sign of a serious condition.
  • ■ new symptoms occur

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

■ do not take more than 4 doses in any 24-hour period
■ dose as follows or as directed by a doctor ■ mL= milliliter

adults and children 12 years of age and over:30 mL (2 TBSP) every 6 to 8 hours, not to exceed 120 mL (8 TBSP) per 24 hours
children 6 to under 12 years of age:15 mL (1 TBSP) every 6 to 8 hours, not to exceed 60 mL (4 TBSP) per 24 hours
children under 6 years:consult a doctor.

Other information

■ store at 20° to 30°C (68° to 86°F)
■ each 15 mL (1 TBSP) contains: Sodium 8.5 mg

Inactive ingredients

citric acid anhydrous, glycerin, propylene glycol, purified water, sodium benzoate, sodium citrate, sodium saccharin, sorbitol

Questions?

1-888-535-0305 9 a.m. - 5 p.m. CST

Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.

U.S. Pat: 9,463,191

Distributed by: GM Pharmaceuticals, Inc. Fort Worth, TX 76118

NDC 58809-189-08

VANACOF ® CP

Allergy / Cough

Each 15 mL (1 TBSP) contains:

Chlophedianol HCl .................... 12.5 mg

Pyrilamine Maleate ....................... 25 mg

Cough Suppressant • Antihistamine

Alcohol Free / Sugar Free / Gluten Free / Dye Free

GM Pharmaceuticals, Inc.

8 fl oz (237 mL)

VanaCof CP

VANACOF CP ALLERGY / COUGH 
chlophedianol hcl, pyrilamine maleate solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58809-189
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLOPHEDIANOL HYDROCHLORIDE (UNII: 69QQ58998Y) (CHLOPHEDIANOL - UNII:42C50P12AP) CHLOPHEDIANOL HYDROCHLORIDE12.5 mg  in 15 mL
PYRILAMINE MALEATE (UNII: R35D29L3ZA) (PYRILAMINE - UNII:HPE317O9TL) PYRILAMINE MALEATE25 mg  in 15 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SORBITOL (UNII: 506T60A25R)  
GLYCERIN (UNII: PDC6A3C0OX)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58809-189-08237 mL in 1 BOTTLE; Type 0: Not a Combination Product12/06/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01212/06/2023
Labeler - GM Pharmaceuticals, INC (793000860)

Revised: 12/2023
Document Id: 0ce20887-e32d-ed7a-e063-6394a90a3624
Set id: 0bdea30a-39da-6611-e063-6394a90aa4cf
Version: 4
Effective Time: 20231219
 
GM Pharmaceuticals, INC